Geode Capital Management, LLC Vaxcyte, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,287,375 shares of PCVX stock, worth $173 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,287,375

Previous 1,973,506 15.9%

Holding current value

$173 Million

Previous $124 Million 26.07%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$59.79 - $81.05 $18.8 Million - $25.4 Million	313,869 Added 15.9%	2,287,375 $156 Million
Q4 2023 Feb 13, 2024	BUY	$45.35 - $63.41 $4.46 Million - $6.24 Million	98,392 Added 5.25%	1,973,506 $124 Million
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $8.74 Million - $10.1 Million	189,900 Added 11.27%	1,875,114 $95.6 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $12.3 Million - $19.2 Million	355,875 Added 26.77%	1,685,214 $84.2 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $2.83 Million - $3.68 Million	77,906 Added 6.23%	1,329,339 $49.8 Million

Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $7.34 Million - $17.1 Million	356,647 Added 39.86%	1,251,433 $60 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $2.5 Million - $3.28 Million	115,091 Added 14.76%	894,786 $21.5 Million
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $1.02 Million - $1.53 Million	57,732 Added 8.0%	779,695 $17 Million
Q1 2022 May 13, 2022	BUY	$17.46 - $26.36 $1.16 Million - $1.75 Million	66,246 Added 10.1%	721,963 $17.4 Million
Q4 2021 Feb 11, 2022	BUY	$19.32 - $26.45 $485,898 - $665,217	25,150 Added 3.99%	655,717 $15.6 Million
Q3 2021 Nov 12, 2021	BUY	$20.26 - $26.97 $2.26 Million - $3.01 Million	111,593 Added 21.5%	630,567 $16 Million
Q2 2021 Aug 13, 2021	BUY	$16.45 - $24.06 $1.61 Million - $2.36 Million	98,086 Added 23.3%	518,974 $11.7 Million
Q1 2021 May 12, 2021	BUY	$18.66 - $29.16 $2.25 Million - $3.51 Million	120,311 Added 40.03%	420,888 $8.31 Million
Q4 2020 Feb 12, 2021	BUY	$26.57 - $51.74 $216,917 - $422,405	8,164 Added 2.79%	300,577 $7.99 Million
Q3 2020 Nov 13, 2020	BUY	$26.5 - $55.4 $7.07 Million - $14.8 Million	266,887 Added 1045.55%	292,413 $14.4 Million
Q2 2020 Aug 13, 2020	BUY	$26.15 - $35.45 $667,504 - $904,896	25,526 New	25,526 $806,000

Others Institutions Holding PCVX

# of Institutions

269

Shares Held

97.1M

Call Options Held

202K

Put Options Held

147K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.48B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Vaxcyte, Inc. Transaction History